Brains Tumours: Cancer By Finlay McKibbin oGe3 Which part of the bedy dees it affect? Brain tumours effect the brain, being formed in its glial cells, which grow from the supporting cells of the brain These tumours are known as "gliomas. Considering they develop in the brain, they are formally known as primary brain tumours. Also, the part of the brain the brain tumour effects, changes the symptoms and treatments for the individual. Common Symptoms. The common symptoms of brain tumours are; Headaches: being the most common symptom, being both severe and persistent in few cases, and can come or go Seizures Nausea and vomiting Difficulty when speaking or being able to recall words Disturbed vision, hearing, smell, and or taste Weakness and or
The brain is made up of millions upon millions of cells. These cells are formed from before birth, up until about 7 years old. Once these brain cells stop dividing, they are never meant to divide again. You can see that the division of brain cells is under strict regulation and control. When this control is lost in a single cell, then it starts dividing in an uncontrolled manner. All of the data obtained through research on cancer shows that this disease is caused by a rapidly dividing cell, with no regulators to stop it from dividing. As the cell makes more and more copies of itself, it grows to form a tumor. This is known as cancer.
The American cancer society estimated that 18,500 people would be diagnosed with brain tumor and those 12,760 men and women would die of brain cancer in 2005.The National Cancer Institute (NCI) estimated that 22,070 new cases of brain and other central nervous system (CNS) cancers would be diagnosed in the United States in 2009. The American Brain Tumor Association (ABTA) clarifies this statistic further by estimating that 62,930 new cases of primary brain tumors would be diagnosed in 2010. By the year 2030, there will be 26 million new cases, and the death toll will reach to around 1.7 million people. According to World Health Organization (WHO), there are more than 120 types of brain tumors.
Neuro-Oncology is the study of cancer in the brain, skull base, or spinal cord. They can also treat genetic disorders of a certain type such as Neurofibromatosis. Neurofibromatosis is tumors that grow in the nervous system that is caused by a genetic disorder. The main purpose of the research was to gain information on Neuro- oncology, general information on brain tumors, and general information on specific tumor types. Central nervous system tumors include various gliomas such as glioblastoma multiforme, astrocytoma, brainstem glioma, ependymoma, and oligodendroglioma. Furthermore, meningioma and vestibular schwannomas. Other conditions neuro-oncologist can treat are central nervous system lymphoma, metastic disease to the spine
Primary brain cancer develops from cells within the brain. Part of the central nervous system (CNS), the brain is the control center for vital functions of the body, including speech, movement, thoughts, feelings, memory, vision, hearing and more.
Brain cancer develops from cells within the brain. The brain controls the vital functions of the body, including, speech, movement, thoughts, feelings, memory, sight, hearing, and more. Brain cancer affects people in many different ways. Brain cancer is diagnosed at the local stage in 76.6% of people. The 5-year survival for localized brain and other nervous system cancer is 36.3%. Brain cancer will cause anything from headaches to balance and walking problems, changes in your vision, muscle twitches, memory problems, and nausea and vomiting.
Glioblastoma (pronounced like gleO blastoma) is an incurable brain cancer,Survival rate is usually measured in months.This became a word that was instantly defined, researched, dissected, feared, and tried to comprehend and understand by family,friends and acquaintances of Larry McKee (McKee)who was personally affected from this single word, it was quickly added to their vocabulary, because of the of the events that transpired on October 22, 2011 that forever changed lives “Glioblastomas are tumors that arise from the astrocytes- the star-shaped cells that make up the “glue-like,” or supportive tissue of the brain. These tumors are usually highly malignant (cancerous) because the cells reproduce quickly and they are supported by a large network of blood vessels.”(A.B.T A..) He was diagnosed with stage four.
What is Cancer? Cancer is many diseases which involve abnormal cell growth. Cancer cells are able to replicate and spread because they completely lose control and are not able to be restrained. These cells will then form to become tumors. There are two types of tumors called malignant and benign. The malignant tumor is the cancerous tumor. The benign tumors are much less destructive to the body. To tell the difference is quite simple, a malignant tumor has the ability to spread through metastasis causing the cancer to attack multiple areas, whereas the benign tumors cannot spread and are in most cases nonthreatening. Although there are numerous types of cancer, such as breast cancer, lung cancer, and kidney cancer, I chose to write about brain
Dr Jennifer Chan, the head of this tumor research, is an Associate Professor & Neuropathologist in the Department of Pathology & Laboratory Medicine, Oncology, and Clinical Neuroscience in the University of Calgary. Besides her work on education, she is also directing a tumorigenesis research team at the University of Calgary, and a tumor banking program which supports pediatric cancer research. Nonetheless, she is also a member of both the Southern Alberta Cancer Research Institute and the Experimental and Applied Therapeutics Program (ExpAT).
CNS tumors represent the second most frequent tumor of childhood and the most common pediatric solid tumor; approximately 2,200 patients under the age of 20 are diagnosed each year with invasive CNS tumors, and CNS tumors are the number one cause of death from childhood cancer.  Therapeutic strategies generally involve surgery as a primary intervention, but complete resection is often not possible due to tumor location. In such cases, adjunct therapies, including chemotherapy and radiation therapy, may be required based on the tumor histology and presence of residual tumor. 
The name of a brain tumor derives from the cells where it forms. Ependymoma starts in the ependymal cells. The ependymal cells line the ventricles in the brain and central canal of the spinal cord (ABTA, n.d.). These two areas, the brain and the spine, make up the central nervous system that controls many significant functions like speech, thought, and physical movement. Ependymoma is in a category of brain tumors called gliomas. A glioma grows from glial cells, a supportive cell found in the brain (ASCO, n.d.).
A person has a 0.55–0.7% chance of developing any type of brain tumor in their lifetime (Mohammadi and Schroeder 1). A brain tumor is a mass of abnormal cells located somewhere in the brain. Brain tumors can be caused by many different disorders including Tuberous Sclerosis Complex (TSC). Some tumors caused by this disorder are inoperable. Inoperable brain tumors can now be treated using new advanced technology. Technological advances provide new hope for patients who have inoperable brain tumors and TSC.
Common malignant brain cancers increase significantly according to statistical data collected by the National Cancer Institute. In 1984, the annual incidence rates of primary brain tumor and primary brain lymphoma also increased notably, the rate of lymphoma almost tripling,
The concept of neurogenesis being confined to the embryonic stage became less obvious with the onset of discovery of neural stem cells maintained in two distinct regions of the mammalian adult brain namely dentate gyrus (DG) of the hippocampus and the sub ventricular zone (SVZ) of the forebrain lateral ventricles14,18,19. What makes these neural stem cells a more credible target for oncogenic transformation? The continual presence of undifferentiated, mitotically active, self renewable stem cells at the apex of the hierarchy bundled in discrete germinal niches in the mammalian brain throughout the lifespan of an organism allows them to accumulate mutations, thus rendering them vulnerable for neoplastic reprogramming. There has been increasing evidence that the genetic and epigenetic mechanisms that initiate and maintain the NSC developmental state are possibly deregulated in GB to emerge as Glioma initiating cells or Brain tumor stem cells20. The discovery of BTSC has high clinical significance in the neuro-oncology field, as evidenced by major diverse roles it plays in various aspects of tumor growth such as tumor initiation, maintenance, progression, angiogenesis and tumor recurrence owing to therapeutic resistance, some of which are described